Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Eugene Science Increases Japanese Distribution, Product Lines; Nihon Pharmaceuticals to Launch CZTM-Enhanced Cosmetic Line

Abstract:
Eugene Science Inc. (OTCBB: EUSI), a leader in the nutraceutical marketplace with its cholesterol lowering CholZero (CZ™) plant sterols, today announced it has retained Early Bird, Inc. (EBI) to market the Company's existing and newly expanded CZ™ plant sterol product lines throughout Japan.

Eugene Science Increases Japanese Distribution, Product Lines; Nihon Pharmaceuticals to Launch CZTM-Enhanced Cosmetic Line

LOS ANGELES, CA | Posted on January 23rd, 2008

EBI has contracted with Nihon Pharmaceutical Co., Ltd. to produce and distribute a CZ™ plant sterol enhanced cosmetic product line including skin cream, toothpaste, shampoos and pet goods -- initial launch is slated for first quarter, 2008. Based in Tokyo, Japan, Nihon generates approximately $1.6 billion in annual sales, was founded in 1921 and has about 560 employees. Nihon, through its subsidiaries, will also distribute CZ™ enhanced food products including pre-cooked rice, cooking oil, capsules, tablets, seaweed, dairy products and ice cream.

EBI expects to develop numerous production and distribution agreements with leading Japanese food, beverage and cosmetic manufacturers and distributors for the expanding Eugene Science CZ™ product lines.

The National Institutes of Health reports an estimated 80 percent of Americans currently have some form of periodontal, or gum, disease. Separately, research indicates that topically applied, plant sterols have chemical properties that are ideally suited for treating and preventing periodontal disease -- rendering sterols the preferred, natural additive for toothpaste for humans and animals alike.

Until now, the active ingredients in conventional plant sterols were too large at the molecular level to be effectively absorbed by gum tissue for use in toothpaste, or by human skin for use in moisturizing anti-aging creams, to deliver their healing benefits. Eugene Science's unique, patented nano-technology process for its CZ™ sterols, however, renders sterols into water dispersible, nano-sized particles that can permeate gum tissue and skin dramatically more effectively than conventional sterols to deliver powerful health benefits.

"Japan is the world's most sophisticated marketplace for nutraceutical food, beverage and cosmetic products as consumers are highly aware of nutraceutical benefits," said Seung Kwon Noh, Chief Executive Officer, Eugene Science. "Europe, North America and the rest of Asia look to and track new product introduction in Japan, providing Eugene Science both strategic advantage as well as strong near term revenue upside. Early Bird is off to a strong start with its Nihon agreement and we are confident this success will accelerate throughout 2008 and beyond."

To be added to Eugene Science's investor lists, please contact Zachary Bryant at or at 818-382-9718.

####

About Eugene Science Inc.
Based in Seoul, Korea, Eugene Science is a global biotechnology company tackling ailments such as heart disease, obesity and diabetes through innovation in the nutraceutical field. Its first commercial heart disease product, CZ™, is a patented, nanoscience-based, water-dispersible functional food ingredient containing natural plant sterols that help maintain healthy cholesterol levels by inhibiting its absorption. CZ™ is available in capsule form, or as a food or beverage additive. These plant sterols are approved by the U.S. FDA for health claims related to cholesterol lowering efficacy. Please visit www.eugene21.com.

Forward-Looking Statements: This document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In addition, from time to time, Eugene Science, or its representatives, have made or may make forward-looking statements, orally or in writing. The words "estimate," "project," "potential," "intended," "expect," "anticipate," "believe" and similar expressions or words are intended to identify forward-looking statements. Such forward-looking statements may be included in, but are not limited to, various filings made by Eugene Science with the United States Securities and Exchange Commission (available at www.sec.gov), press releases or oral statements made with the approval of an authorized executive officer of Eugene Science. Actual results could differ materially from those projected or suggested in any forward-looking statements as a result of a wide variety of factors and conditions. Reference is hereby made to Eugene Science's Annual Report on Form 10-KSB for the fiscal year ended December 31, 2006 for information regarding those factors and conditions. Among the important factors that could cause actual results to differ materially from management's projections, estimates and expectations include, but are not limited to: changing economic influences in the nutraceutical or cosmetic industry; dependence on key personnel; actions of third parties; the market for cosmetic or nutraceutical products containing Eugene Science's CZ™ ingredient; and availability of adequate financing. Readers are cautioned not to place undue reliance upon these forward-looking statements that speak only as of the date of this press release. Eugene Science undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.

For more information, please click here

Contacts:
Investor Contact:
Investor Relations International
Zachary Bryant
Senior Vice President and Account Group Manager
818.382.9700

Company Contact for CZ™ Sales and Distribution
U.S. Headquarters (Los Angeles)
Tel: 213.384.5008
E: Email Contact
Early Bird Inc.
Chris Craney
President
Tel: 81-3-5789-5416

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Characterizing inkjet inks: Malvern Instruments presents new rheological research April 23rd, 2014

NanoSafe, Inc. announces the addition of the Labconco Protector® Glove Box to its NanoSafe Tested™ registry April 23rd, 2014

Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014

High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014

Nanomedicine

QuantuMDx announce prototype handheld lab for 15 minute malaria diagnosis and drug resistance testing April 23rd, 2014

Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014

Cloaked DNA nanodevices survive pilot mission: Successful foray opens door to virus-like DNA nanodevices that could diagnose diseased tissues and manufacture drugs to treat them April 22nd, 2014

Berkeley Lab Researchers Demonstrate First Size-based Chromatography Technique for the Study of Living Cells April 22nd, 2014

Announcements

Characterizing inkjet inks: Malvern Instruments presents new rheological research April 23rd, 2014

NanoSafe, Inc. announces the addition of the Labconco Protector® Glove Box to its NanoSafe Tested™ registry April 23rd, 2014

Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014

High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014

Personal Care

Good vibrations: Using light-heated water to deliver drugs - Researchers use near-infrared light to warm water-infused polymeric particles April 1st, 2014

Iranian Food Industry Utilizes Lipid Nanocarriers for Beta-Carotene Enrichment January 23rd, 2014

ASTM International Nanotechnology Committee Approves Airborne Nanoparticle Measurement Standard December 10th, 2013

Antibacterial Nanocomposites Produced from Offset Lithography Inks December 1st, 2013

Alliances/Partnerships/Distributorships

Economics = MC2 -- A portrait of the modern physics startup: Successful companies founded by physicists often break the Silicon Valley model, according to new American Institute of Physics report April 23rd, 2014

Global leader in solar cell manufacturing eyes New York for major expansion outside of Japan: CNSE and Solar Frontier Explore $700 Million Investment, Job Creation in New York State April 22nd, 2014

ASM International Repositions Brand and Introduces New Logo; Looks to Future of Materials Science Innovation: New logo celebrates organization’s history and provides fresh elements for future growth April 21st, 2014

Virus structure inspires novel understanding of onion-like carbon nanoparticles April 10th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE